STRATA Skin Sciences Inc - Asset Resilience Ratio
STRATA Skin Sciences Inc (SSKN) has an Asset Resilience Ratio of 0.00% as of June 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2004–2017)
This chart shows how STRATA Skin Sciences Inc's Asset Resilience Ratio has changed over time. Check STRATA Skin Sciences Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down STRATA Skin Sciences Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see STRATA Skin Sciences Inc (SSKN) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: STRATA Skin Sciences Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
STRATA Skin Sciences Inc Industry Peers by Asset Resilience Ratio
Compare STRATA Skin Sciences Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.30% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
Novacyt
PA:ALNOV |
Medical Devices | 0.02% |
|
Implanet SA
PA:ALIMP |
Medical Devices | 0.55% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Annual Asset Resilience Ratio for STRATA Skin Sciences Inc (2004–2017)
The table below shows the annual Asset Resilience Ratio data for STRATA Skin Sciences Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 0.00% | $0.00 | $38.63 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $43.19 Million | -- |
| 2015-12-31 | 0.03% | $15.00K | $51.37 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $20.07 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $14.13 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $17.27 Million | -- |
| 2011-12-31 | 0.00% | $0.00 | $31.39 Million | -- |
| 2008-12-31 | 2.35% | $390.51K | $16.62 Million | -5.43pp |
| 2007-12-31 | 7.78% | $1.72 Million | $22.11 Million | -85.15pp |
| 2004-12-31 | 92.93% | $6.59 Million | $7.10 Million | -- |
About STRATA Skin Sciences Inc
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer … Read more